239
Views
37
CrossRef citations to date
0
Altmetric
Original Research

Hesperidin Supplementation Modulates Inflammatory Responses Following Myocardial Infarction

, PhD, , DMD, , PhD, , PhD, & , Msc
Pages 205-211 | Received 23 Dec 2013, Accepted 01 Feb 2014, Published online: 11 Mar 2015

REFERENCES

  • Tehrani DM, Seto AH: Third universal definition of myocardial infarction: update, caveats, differential diagnoses. Cleve Clin J Med 80:777–786, 2013.
  • Ghuge GD, Zine R, Mogrekar MR: High sensitivity C-reactive protein, paraxonase 1 and high density lipoprotein cholesterol in myocardial infarction. Int J Biomed Adv Res 3:637–639, 2012.
  • Suefuji H, Ogawa H, Yasue H, Sakamoto T, Miyao Y, Kaikita K, Soejima H, Misumi K, Miyamoto S, Kataoka K: Increased plasma level of soluble E-selectin in acute myocardial infarction. Am Heart J 140:243–248, 2000.
  • Shojaie M, Sotoodah A, Shafaie G: Is Adiponectin associated with acute myocardial infarction in Iranian non obese patients? Lipids Health Dis 28:8–17, 2009.
  • Ambroziak M, Bartoszewicz Z, Budaj A: Total and high molecular weight adiponectin are decreased in young patients with myocardial infarction. J Am Coll Cardiol 59:E530–E530, 2012.
  • Gustafson B: Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 17:332–341, 2010.
  • Akram S, Ahmed Z, Fayyaz I, Mehmood S, Ghani M, Choudhary AM, Shah I: Serum leptin levels in patients with coronary artery disease. J Ayub Med Coll Abbottabad 23:13–14, 2011.
  • Kim SW, Kim CE, Kim MH: Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells. Biochem Biophys Res Commun 415:602–607, 2011.
  • Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A: Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 93:73–80, 2011.
  • Raza SS, Khan MM, Ahmad A, Ashafaq M, Khuwaja G, Tabassum R, Javed H, Siddiqui MS, Safhi MM, Isalam F: Hesperidin ameliorates functional and histological outcome and reduces neuroinflammation in experimental stroke. Brain Res 1420:93–105, 2011.
  • Haidari F, Keshavarz SA, Rashidi MR, Mohammad Shahi M: Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity. J Clin Biochem Nutr 45:285–291, 2009.
  • Haidari F, Rashidi MR, Mohammad Shahi M: Effects of orange juice and hesperetin on serum paraxonase activity and lipid profile in hyperuricemic rats. BioImpacts 2:39–45, 2012.
  • Sahu BD, Kuncha M, Sindhura GJ, Sistla R: Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine 20:453–460, 2013.
  • Wolin KY, Heil DP, Askew S, Matthews CE, Bennett GG: Validation of the International Physical Activity Questionnaire–Short among blacks. J Phys Act Health 5:746–760, 2008.
  • Wang X, Hasegawa J, Kitamura Y, Wang Z, Matsuda A, Shinoda W, Miura N, Kimura K: Effects of hesperidin on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. J Pharmacol Sci 117:129–138, 2011.
  • Yasim A, Ozbag D, Kilinc M, Ciralik H, Toru I: The effects of diosmin–hesperidin combination treatment on the lipid profile and oxidative–antioxidative system in high-cholesterol diet-fed rats. Türk Göğüs Kalp Damar Cer Derg 19:55–61, 2011.
  • Akiyama S, Katsumata S, Suzuki K, Ishimi Y, Wu J, Uehara M: Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J Clin Biochem Nutr 46:87–92, 2010.
  • Akiyama S, Katsumata S, Suzuki K, Nakaya Y, Ishimi Y, Uehara M: Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci Biotechnol Biochem 73:2779–2782, 2009.
  • Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ: Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 96:E782–E792, 2011.
  • Ala A, Dhillon AP, Hodgson HJ: Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. Int J Exp Pathol 84:1–16, 2003.
  • Suefuji H, Ogawa H, Yasue H, Sakamoto T, Miyao Y, Kaikita K, Soejima H, Misumi K, Miyamoto S, Kataoka K: Increased plasma level of soluble E-selectin in acute myocardial infarction. Am Heart J 140:243–248, 2000.
  • Piestrzeniewicz K, Luczak K, Komorowski J, Maciejewski M, Piechowiak M, Jankiewicz-Wika J, Goch JH: Obesity and adiponectin in acute myocardial infarction. Cardiol J 14:29–36, 2007.
  • Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piché LA, Serratore P: HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr 72:1095–1100, 2000.
  • Cesar TB, Aptekmann NP, Araujo MP, Vinagre CC, Maranhão RC: Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects. Nutr Res 30:689–694, 2010.
  • Miwa Y, Yamada M, Sunayama T, Mitsuzumi H, Tsuzaki Y, Chaen H, Mishima Y, Kibata M: Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level. J Nutr Sci Vitaminol (Tokyo) 50:211–218, 2004.
  • Demonty I, Lin Y, Zebregs YE, Vermeer MA, van der Knaap HC, Jäkel M, Trautwein EA: The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J Nutr 140:1615–1620, 2010.
  • Kim HJ, Jeon SM, Lee MK, Cho YY, Kwon EY, Lee JH, Choi MS: Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. J Med Food 13:808–814, 2010.
  • Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C: Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. Curr Pharm Des 18:1519–1530, 2012.
  • Grassi D, Desideri G, Croce G, Tiberti S, Aggio A, Ferri C: Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 15:1072–1084, 2009.
  • Actis-Goretta L, Ottaviani JI, Fraga CG: Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agr Food Chem 54:229–234, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.